<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="13181">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01782807</url>
  </required_header>
  <id_info>
    <org_study_id>kmc0029-11</org_study_id>
    <nct_id>NCT01782807</nct_id>
  </id_info>
  <brief_title>Ovarian Function After Hysterectomy With or Without Fimbriectomy or Salpingectomy</brief_title>
  <official_title>Ovarian Function After Hysterectomy With or Without Fimbriectomy or Salpingectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaplan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kaplan Medical Center</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The impact of Hysterectomy with preservation of the ovaries on ovarian function has long
      been controversial. studies have shown conflicting data regarding ovarian function after
      simple Hysterectomy.

      In recent years, there is a growing evidence that Salpingectomy or Fimbriectomy may have
      preventive value reducing Ovarian and Primary Peritoneal carcinoma, but the safety and the
      consequences regarding ovarian function have yet to be established.

      The aim of this study is to evaluate ovarian function after Hysterectomy alone Vs.
      Hysterectomy combined with salpingectomy or fimbriectomy
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2011</start_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Ovarian function</measure>
    <time_frame>60 days post-operative</time_frame>
    <safety_issue>No</safety_issue>
    <description>ovarian function measured by FSH , AMH and follicule count on ultra-sound</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Ovarian Function Insufficiency</condition>
  <arm_group>
    <arm_group_label>Hysterectomy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Hysterectomy without oophorectomy or salpingectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hysterctomy with salpingectomy or fimbriectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Salpingectomy or Fimbriectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Salpingectomy or Fimbriectomy</intervention_name>
    <arm_group_label>Hysterctomy with salpingectomy or fimbriectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women undergoing Hysterectomy for Benign In dication (eg. Uterus Myomatous) before
             menopause

        Exclusion Criteria:

          -  Menopause

          -  known or suspected malignancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alon Ben- Arie, MD</last_name>
    <phone>00-972-50-2460001</phone>
    <email>abenarie@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yael Naaman, MD</last_name>
    <phone>00-972-52-3499377</phone>
    <email>yaelnaa@gmail.con</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kaplan Medical Center</name>
      <address>
        <city>Rehovot</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alon Ben- Arie, MD</last_name>
      <email>abenarie@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Yael Naaman, MD</last_name>
      <email>yaelnaa@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Alon Ben- Arie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Maseela T, Scheele R. [Hysterosalpingectomy. A contribution to the prevention of primary tubal neoplasms]. Fortschr Med. 1980 Jun 5;98(21):818-22. German.</citation>
    <PMID>7409710</PMID>
  </reference>
  <reference>
    <citation>Zalel Y, Lurie S, Beyth Y, Goldberger S, Tepper R. Is it necessary to perform a prophylactic oophorectomy during hysterectomy? Eur J Obstet Gynecol Reprod Biol. 1997 May;73(1):67-70.</citation>
    <PMID>9175692</PMID>
  </reference>
  <reference>
    <citation>Morse AN, Hammer RA, Walter AJ, Baker S, Magtibay PM. Does hysterectomy without adnexectomy in patients with prior tubal interruption increase the risk of subsequent hydrosalpinx? Am J Obstet Gynecol. 2002 Dec;187(6):1483-5; discussion 1485-6.</citation>
    <PMID>12501050</PMID>
  </reference>
  <reference>
    <citation>Farquhar CM, Sadler L, Harvey SA, Stewart AW. The association of hysterectomy and menopause: a prospective cohort study. BJOG. 2005 Jul;112(7):956-62.</citation>
    <PMID>15957999</PMID>
  </reference>
  <reference>
    <citation>Riedel HH, Lehmann-Willenbrock E, Semm K. Ovarian failure phenomena after hysterectomy. J Reprod Med. 1986 Jul;31(7):597-600.</citation>
    <PMID>3746790</PMID>
  </reference>
  <reference>
    <citation>Bulent Tiras M, Noyan V, Ozdemir H, Guner H, Yildiz A, Yildirim M. The changes in ovarian hormone levels and ovarian artery blood flow rate after laparoscopic tubal sterilization. Eur J Obstet Gynecol Reprod Biol. 2001 Dec 1;99(2):219-21.</citation>
    <PMID>11788175</PMID>
  </reference>
  <verification_date>June 2011</verification_date>
  <lastchanged_date>January 31, 2013</lastchanged_date>
  <firstreceived_date>January 31, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kaplan Medical Center</investigator_affiliation>
    <investigator_full_name>Lion Poles</investigator_full_name>
    <investigator_title>Deputy Director of Kaplan Medical Center</investigator_title>
  </responsible_party>
  <keyword>Ovarian function</keyword>
  <keyword>Hysterectomy</keyword>
  <keyword>Salpingectomy</keyword>
  <keyword>Anti mullerian hormone</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
